1
/
of
1
Elabscience
SKU:PKSM041423
Recombinant Mouse B-cell Receptor CD22/Siglec-2/CD22 (C-6His)
Recombinant Mouse B-cell Receptor CD22/Siglec-2/CD22 (C-6His)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Mouse B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS), a cutting-edge product designed to revolutionize the field of immunology. This meticulously engineered recombinant protein offers unparalleled specificity and functionality, making it an indispensable tool for researchers and scientists alike.
The Recombinant Mouse B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS) boasts a unique composition that enables it to effectively bind to CD22, a crucial receptor found on B-cells. This interaction plays a pivotal role in regulating B-cell activation and signaling, making it an invaluable target for therapeutic interventions and immunological studies.
Crafted with utmost precision, this recombinant protein exhibits exceptional purity and stability, ensuring consistent and reliable results in a wide range of experimental settings. Its high affinity for CD22 guarantees optimal binding efficiency, facilitating accurate and reproducible data acquisition.
Furthermore, the inclusion of a C-6HIS tag enhances the versatility of this product, enabling facile purification and detection through affinity chromatography and Western blotting techniques. This feature streamlines experimental workflows, saving valuable time and resources.
The Recombinant Mouse B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures. Each batch undergoes rigorous testing to ensure batch-to-batch consistency, guaranteeing the utmost reliability and reproducibility.
In summary, the Recombinant Mouse B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS) represents a groundbreaking advancement in the field of immunology. Its exceptional specificity, stability, and versatility make it an indispensable tool for researchers seeking to unravel the intricacies of B-cell biology and develop novel therapeutic strategies. Embrace this innovative product and unlock new frontiers in immunological research.
The Recombinant Mouse B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS) boasts a unique composition that enables it to effectively bind to CD22, a crucial receptor found on B-cells. This interaction plays a pivotal role in regulating B-cell activation and signaling, making it an invaluable target for therapeutic interventions and immunological studies.
Crafted with utmost precision, this recombinant protein exhibits exceptional purity and stability, ensuring consistent and reliable results in a wide range of experimental settings. Its high affinity for CD22 guarantees optimal binding efficiency, facilitating accurate and reproducible data acquisition.
Furthermore, the inclusion of a C-6HIS tag enhances the versatility of this product, enabling facile purification and detection through affinity chromatography and Western blotting techniques. This feature streamlines experimental workflows, saving valuable time and resources.
The Recombinant Mouse B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures. Each batch undergoes rigorous testing to ensure batch-to-batch consistency, guaranteeing the utmost reliability and reproducibility.
In summary, the Recombinant Mouse B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS) represents a groundbreaking advancement in the field of immunology. Its exceptional specificity, stability, and versatility make it an indispensable tool for researchers seeking to unravel the intricacies of B-cell biology and develop novel therapeutic strategies. Embrace this innovative product and unlock new frontiers in immunological research.
Share
